Discovery and evaluation of inhibitors of human sphingosine kinase

Cancer Research

Volumn 63, Issue 18, 2003, Pages 5962-5969

  French, Kevin J ^a   Schrecengost, Randy S ^a   Lee, Brian D ^a   Zhuang, Yan ^a   Smith, Staci N ^a   Eberly, Justin L ^a   Yun, Jong K ^a   Smith, Charles D ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3,4 DIHYDROXYBENZYLIDENE)BENZOFURAN 3 ONE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; CERAMIDE; DIHYDROXYAURONE; ENZYME INHIBITOR; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN KINASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; SPHINGOSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DRUG TARGETING; ENZYME INHIBITION; ENZYME METABOLISM; HUMAN; HUMAN CELL; LIPID METABOLISM; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; VALIDATION PROCESS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME INHIBITORS; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0141507968     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Olivera, A., and Spiegel, S. Sphingosine kinase: a mediator of vital cellular functions. Prostaglandins, 64: 123-134, 2001.
2. Alessenko, A. V. The role of sphingomyelin cycle metabolites in transduction of signals of cell proliferation, differentiation and death. Membr. Cell Biol., 13: 303-320, 2000.
3. Merrill, A. H., Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J. Biol. Chem., 277: 25843-25846, 2002.
4. Hannun, Y. A., and Obeid, L. M. Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci., 20: 73-77, 1995.
5. Ogretmen, B., and Hannun, Y. A. Updates on functions of ceramide in chemotherapy-induced cell death and in mulfidrug resistance. Drug Resist. Updat., 4: 368-377, 2001.
6. Claus, R., Russwurm, S., Meisner, M., Kinscherf, R., and Deigner, H. P. Modulation of the ceramide level, a novel therapeutic concept? Curr. Drug Targets, 1: 185-205, 2000.
7. Xia, P., Gamble, J. R., Wang, L., Pitson, S. M., Moretti, P. A., Wattenberg, B. W., D'Andrea, R. J., and Vadas, M. A. An oncogenic role of sphingosine kinase. Curr. Biol., 10: 1527-1530, 2000.
8. Igarashi, Y., Hakomori, S., Toyokuni, T., Dean, B., Fujita, S., Sugimoto, M., Ogawa, T., el-Ghendy, K., and Racker, E. Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry, 28: 6796-6800, 1989.
9. Megidish, T., White, T., Takio, K., Titani, K., Igarashi, Y., and Hakomori, S. The signal modulator protein 14-3-3 is a target of sphingosine- or N,N-dimethylsphingosine-dependent kinase in 3T3(A31) cells. Biochem. Biophys. Res. Commun., 216: 739-747, 1995.
10. King, C. C., Zenke, F. T., Dawson, P. E., Dutil, E. M., Newton, A. C., Hemmings, B. A., and Bokoch, G. M. Sphingosine is a novel activator of 3-phosphoinositide-dependent kinase I. J. Biol. Chem., 275: 18108-18113, 2000.
11. McDonald, O. B., Hannun, Y. A., Reynolds, C. H., and Sahyoun, N. Activation of casein kinase II by sphingosine. J. Biol. Chem., 266: 21773-21776, 1991.
12. Kono, K., Tanaka, M., Ono, Y., Hosoya, T., Ogita, T., and Kohama, T. S-15183a and b, new sphingosine kinase inhibitors, produced by a fungus. J. Antibiot. (Tokyo), 54: 415-420, 2001.
13. Kono, K., Tanaka, M., Mizuno, T., Kodama, K., Ogita, T., and Kohama, T. B-535a, b and c, new sphingosine kinase inhibitors, produced by a marine bacterium; taxonomy, fermentation, isolation, physico-chemical properties and structure determination. J. Antibiot. (Tokyo), 53: 753-758, 2000.
14. Kono, K., Tanaka, M., Ogita, T., and Kohama, T. Characterization of B-5354c, a new sphingosine kinase inhibitor, produced by a marine bacterium. J. Antibiot. (Tokyo), 53: 759-764, 2000.
15. Pitson, S. M., D'Andrea, R. J., Vandeleur, L., Moretti, P. A., Xia, P., Gamble, J. R., Vadas, M. A., and Wattenberg, B. W. Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes. Biochem. J., 350: 429-441, 2000.
16. Fairchild, C. R., Ivy, S. P., Kao-Shan, C. S., Whang-Peng, J., Rosen, N., Israel, M. A., Melera, P. W., Cowan, K. H., and Goldsmith, M. E. Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res., 47: 5141-5148, 1987.
17. Schneider, E., Horton, J. K., Yang, C. H., Nakagawa, M., and Cowan, K. H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res., 54: 152-158, 1994.
18. Louie, D. D., Kisic, A., and Schroefer, G. J., Jr. Sphingolipid base metabolism. Partial purification and properties of sphinganine kinase of brain. J. Biol. Chem., 251: 4557-4564, 1976.
19. Olivera, A., Barlow, K. D., and Spiegel, S. Assaying sphingosine kinase activity. Methods Enzymol., 311: 215-223, 2000.
20. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. (Bethesda), 82: 1107-1112, 1990.
21. Yuan, S. Y., Hsu, S. L., Tsai, K. J., and Yang, C. R. Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells. Urol. Res., 30: 282-288, 2002.
22. Chen, H. C., and Guan, J. L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA, 91: 10148-10152, 1994.
23. Reiske, H. R., Kao, S. C., Cary, L. A., Guan, J. L., Lai, J. F., and Chen, H. C. Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration. J. Biol. Chem., 274: 12361-12366, 1999.
24. Smith, C. D., Myers, C. B., Zilfou, J. T., Smith, S. N., and Lawrence, D. S. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein. Oncol. Res., 12: 219-229, 2001.
25. Lawrence, D. S., Copper, J. E., and Smith, C. D. Structure-activity studies of substituted quinoxalinones as multiple-drug-resistance antagonists. J. Med. Chem., 44: 594-601, 2001.
26. Shirahama, T., Sweeney, E. A., Sakakura, C., Singhal, A. K., Nishiyama, K., Akiyama, S., Hakomori, S., and Igarashi, Y. In vitro and in vivo induction of apoptosis by sphingosine and N,N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells. Clin. Cancer Res., 3: 257-264, 1997.
27. Zhang, H., Desai, N. N., Olivera, A., Seki, T., Brooker, G., and Spiegel, S. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol., 114: 155-167, 1991.
28. Goodemote, K. A., Mattie, M. E., Berger, A., and Spiegel, S. Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate. J. Biol. Chem., 270: 10272-10277, 1995.
29. Kiss, Z., and Mukherjee, J. J. Phosphocholine and sphingosine-1-phosphate synergistically stimulate DNA synthesis by a MAP kinase-dependent mechanism. FEBS Lett., 412: 197-200, 1997.
30. van Echten-Deckert, G., Schick, A., Heinemann, T., and Schnieders, B. Phosphorylated cis-4-methylsphingosine mimics the mitogenic effect of sphingosine-1-phosphate in Swiss 3T3 fibroblasts. J. Biol. Chem., 273: 23585-23589, 1998.
31. Huang, J. S., Mukherjee, J. J., and Kiss, Z. Ethanol potentiates the mitogenic effects of sphingosine 1-phosphate by a zinc- and calcium-dependent mechanism in fibroblasts. Arch. Biochem. Biophys., 366: 131-138, 1999.
32. Kimura, T., Watanabe, T., Sato, K., Kon, J., Tomura, H., Tamama, K., Kuwabara, A., Kanda, T., Kobayashi, I., Ohta, H., Ui, M., and Okajima, F. Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem. J., 348: 71-76, 2000.
33. Ediger, T. L., and Toews, M. L. Synergistic stimulation of airway smooth muscle cell mitogenesis. J. Pharmacol. Exp. Ther., 294: 1076-1082, 2000.
34. Thamilselvan, V., Li, W., Sumpio, B. E., and Basson, M. D. Sphingosine-1-phosphate stimulates human Caco-2 intestinal epithelial proliferation via p38 activation and activates ERK by an independent mechanism. In Vitro Cell. Dev. Biol. Anim., 38: 246-253, 2002.
35. Van Brocklyn, J., Letterle, C., Snyder, P., and Prior, T. Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase β. Cancer Lett., 181: 195-204, 2002.
36. Van Brocklyn, J. R., Lee, M. J., Menzeleev, R., Olivera, A., Edsall, L., Cuvillier, O., Thomas, D. M., Coopman, P. J., Thangada, S., Liu, C. H., Hla, T., and Spiegel, S. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell Biol., 142: 229-240, 1998.
37. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S., and Spiegel, S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature (Lond.), 381: 800-803, 1996.
38. Nava, V. E., Cuvillier, O., Edsall, L. C., Kimura, K., Milstien, S., Gelmann, E. P., and Spiegel, S. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res., 60: 4468-4474, 2000.
39. Jayadev, S., Liu, B., Bielawska, A. E., Lee, J. Y., Nazaire, F., Pushkareva, M., Obeid, L. M., and Hannun, Y. A. Role for ceramide in cell cycle arrest. J. Biol. Chem., 270: 2047-2052, 1995.
40. Bourbon, N. A., Yun, J., Berkey, D., Wang, Y., and Kester, M. Inhibitory actions of ceramide upon PKC-ε/ERK interactions. Am. J. Physiol. Cell Physiol., 280: C1403-C1411, 2001.
41. Lucci, A., Han, T. Y., Liu, Y. Y., Giuliano, A. E., and Cabot, M. C. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics. Int. J. Oncol., 15: 541-546, 1999.
42. Charles, A. G., Han, T. Y., Liu, Y. Y., Hansen, N., Giuliano, A. E., and Cabot, M. C. Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother. Pharmacol., 47: 444-450, 2001.
43. Perry, D. K., Carton, J., Shah, A. K., Meredith, F., Uhlinger, D. J., and Hannun, Y. A. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem., 275: 9078-9084, 2000.
44. Olivera, A., Kohama, T., Tu, Z., Milstien, S., and Spiegel, S. Purification and characterization of rat kidney sphingosine kinase. J. Biol. Chem., 273: 12576-12583, 1998.
45. Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K., Poulton, S., Milstien, S., Kohama, T., and Spiegel, S. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem., 275: 19513-19520, 2000.
46. Pyne, S., and Pyne, N. J. Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J., 349: 385-402, 2000.
47. Olivera, A., and Spiegel, S. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature (Lond.), 365: 557-560, 1993.
48. 2+ signalling by epidermal growth factor receptor. FEBS Lett., 461: 217-222, 1999.
49. Xia, P., Wang, L., Gamble, J. R., and Vadas, M. A. Activation of sphingosine kinase by tumor necrosis factor-α inhibits apoptosis in human endothelial cells. J. Biol. Chem., 274: 34499-34505, 1999.
50. Goetzl, E. J., Dolezalova, H., Kong, Y., Hu, Y. L., Jaffe, R. B., Kalli, K. R., and Conover, C. A. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res., 59: 5370-5375, 1999.
51. Lee, M. J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. I., and Hla, T. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell, 99: 301-312, 1999.
52. Hegedus, T., Orfi, L., Seprodi, A., Varadi, A., Sarkadi, B., and Keri, G. Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDRI and MRP1. Biochim. Biophys. Acta, 1587: 318-325, 2002.